Quadrant Capital Group’s CME Group CME Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$2.99M Buy
10,124
+2,482
+32% +$737K 0.09% 177
2025
Q4
$2.09M Buy
7,642
+24
+0.3% +$6.52K 0.06% 249
2025
Q3
$2.06M Buy
7,618
+75
+1% +$20.4K 0.07% 240
2025
Q2
$2.08M Buy
7,543
+297
+4% +$80.8K 0.07% 217
2025
Q1
$1.92M Buy
7,246
+4,152
+134% +$1.02M 0.07% 200
2024
Q4
$719K Buy
3,094
+101
+3% +$23.2K 0.05% 252
2024
Q3
$660K Buy
2,993
+33
+1% +$6.83K 0.05% 281
2024
Q2
$582K Sell
2,960
-139
-4% -$28.7K 0.04% 288
2024
Q1
$667K Sell
3,099
-612
-16% -$129K 0.05% 263
2023
Q4
$782K Buy
3,711
+328
+10% +$70K 0.07% 211
2023
Q3
$677K Buy
3,383
+195
+6% +$38.8K 0.07% 209
2023
Q2
$591K Sell
3,188
-256
-7% -$47.3K 0.06% 227
2023
Q1
$660K Buy
3,444
+901
+35% +$163K 0.07% 211
2022
Q4
$428K Buy
2,543
+3
+0.1% +$521 0.05% 281
2022
Q3
$450K Sell
2,540
-114
-4% -$22.5K 0.06% 226
2022
Q2
$543K Buy
2,654
+203
+8% +$43K 0.07% 201
2022
Q1
$583K Buy
2,451
+118
+5% +$27.7K 0.07% 200
2021
Q4
$533K Buy
2,333
+206
+10% +$45.3K 0.06% 200
2021
Q3
$411K Sell
2,127
-62
-3% -$12.6K 0.06% 219
2021
Q2
$466K Buy
2,189
+516
+31% +$109K 0.07% 198
2021
Q1
$342K Buy
1,673
+398
+31% +$78.4K 0.06% 234
2020
Q4
$232K Sell
1,275
-301
-19% -$51.2K 0.04% 269
2020
Q3
$264K Buy
1,576
+187
+13% +$31.5K 0.06% 209
2020
Q2
$226K Sell
1,389
-1,908
-58% -$342K 0.05% 243
2020
Q1
$571K Buy
3,297
+755
+30% +$150K 0.1% 185
2019
Q4
$486K Buy
2,542
+318
+14% +$65.2K 0.06% 316
2019
Q3
$452K Buy
2,224
+75
+3% +$15.7K 0.07% 281
2019
Q2
$403K Buy
2,149
+438
+26% +$80.7K 0.06% 300
2019
Q1
$267K Buy
1,711
+360
+27% +$63.6K 0.05% 396
2018
Q4
$239K Buy
1,351
+194
+17% +$35.8K 0.06% 288
2018
Q3
$184K Buy
1,157
+22
+2% +$3.7K 0.05% 261
2018
Q2
$174K Sell
1,135
-5
-0.4% -$817 0.06% 272
2018
Q1
$168K Buy
1,140
+9
+0.8% +$1.43K 0.06% 279
2017
Q4
$152K Buy
1,131
+16
+1% +$2.28K 0.06% 288
2017
Q3
$145K Buy
1,115
+171
+18% +$21.6K 0.06% 288
2017
Q2
$111K Buy
944
+113
+14% +$13.5K 0.05% 313
2017
Q1
$92K Buy
831
+54
+7% +$6.5K 0.04% 373
2016
Q4
$83K Sell
777
-10
-1% -$1.11K 0.04% 303
2016
Q3
$75K Buy
787
+9
+1% +$940 0.05% 311
2016
Q2
$70K Buy
778
+100
+15% +$9.45K 0.05% 310
2016
Q1
$61K Sell
678
-701
-51% -$63.8K 0.04% 336
2015
Q4
$120K Buy
1,379
+87
+7% +$8.19K 0.08% 213
2015
Q3
$117K Buy
1,292
+67
+5% +$6.37K 0.08% 209
2015
Q2
$112K Buy
+1,225
New +$114K 0.07% 225

Other funds holding CME

Quadrant Capital Group's CME Position: Q1 2026 in Review

Quadrant Capital Group increased its CME Group (CME) stake by 32% in Q1 2026, buying an estimated $737K and bringing the position to 10,124 shares worth $2.99M. The position accounts for 0.09% of the portfolio, ranked #177.

Quadrant Capital Group first reported a position in CME in Q2 2015 and has held it in 44 quarters since. 1,790 funds tracked by Wall St. Rank hold CME as of Q1 2026.

  • Quadrant Capital Group held 10,124 shares of CME Group worth $2.99M as of Q1 2026.
  • Quadrant Capital Group bought 2,482 CME Group shares in Q1 2026, an estimated $737K.
  • CME Group made up 0.09% of Quadrant Capital Group's portfolio in Q1 2026, its #177 holding.
  • Quadrant Capital Group first reported a position in CME Group in Q2 2015 and has held it in 44 quarters since.
  • 1,790 funds tracked by Wall St. Rank held CME Group as of Q1 2026.

Based on Quadrant Capital Group's 13F filing for Q1 2026, filed 11 May 2026.